Literature DB >> 2960742

Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.

J C Edberg1, E Wright, R P Taylor.   

Abstract

We have used direct binding isotherm analyses to measure the association constant (Ka) and number of binding sites for the binding of prepared complement-fixing antibody (Ab)/dsDNA immune complexes (IC) to human red blood cells (RBC). In order to generalize this study we have examined the binding reaction for a number of different anti-dsDNA Ab (from systemic lupus erythematosus plasmas), complement sources, RBC donors, and dsDNA sizes. The affinity of the IC for the RBC is quite high, and the Ka values fall within a narrow range (5 to 14 X 10(10) liter/mol). Similarly, the limiting stoichiometries for the number of IC bound per RBC were between 40 and 91. The very high affinity and limiting stoichiometries both suggest that the IC bind to the RBC via multiple contacts with clusters of complement receptor type 1 (CR1). Furthermore, we have used three specific monoclonal AB (mAb) to quantitate CR1 on human RBC in the presence and absence of bound IC. One of these Ab, mAb 1B4, is blocked from binding to the RBC if IC are previously bound, and we have used this observation to verify the multivalent nature of the interaction of complement-fixing IC with CR1 on human RBC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960742

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).

Authors:  I Csípö; E Kiss; P Soltész; P Antal-Szalmás; G Szegedi; J H Cohen; R P Taylor; M Kávai
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.

Authors:  R P Taylor; W M Sutherland; C J Reist; D J Webb; E L Wright; R H Labuguen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function.

Authors:  Anvay Ukidve; Zongmin Zhao; Alexandra Fehnel; Vinu Krishnan; Daniel C Pan; Yongsheng Gao; Abhirup Mandal; Vladimir Muzykantov; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-14       Impact factor: 11.205

4.  A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).

Authors:  A Repik; S E Pincus; I Ghiran; A Nicholson-Weller; D R Asher; A M Cerny; L S Casey; S M Jones; S N Jones; N Mohamed; L B Klickstein; G Spitalny; R W Finberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

5.  Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro.

Authors:  A L Hepburn; J C Mason; S Wang; C J Shepherd; O Florey; D O Haskard; K A Davies
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

6.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.

Authors:  Ionita Ghiran; Aleksandra M Glodek; Gregory Weaver; Lloyd B Klickstein; Anne Nicholson-Weller
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

8.  Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.

Authors:  I Yokoyama; F Waxman
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

9.  Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection.

Authors:  M Domínguez; A Toraño
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

10.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Authors:  L B Klickstein; T J Bartow; V Miletic; L D Rabson; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.